Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Imolamine is a coronary vasodilator that was historically used in the treatment of angina pectoris and other forms of ischemic heart disease. It exhibits antianginal and metabolic effects, as well as platelet antiaggregating activity. Electrophysiologically, it has been shown to affect His-Purkinje conduction and possess antiarrhythmic properties, particularly in antagonizing digitalis-induced rhythm disorders. However, its clinical use has been largely discontinued due to reports of severe adverse effects, most notably severe cytolytic hepatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on imolamine.